切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - Flk1 - CSF1R - Topoisomerases

19件产品中的 1-10

页面
每页
清除全部
  1. Pexidartinib (PLX3397)
    B5854 Pexidartinib (PLX3397)
     3 Citation
    中文名: 培西达替尼
    Target: FLT3|c-Kit|CSF1R
    Summary: CSF-1R抑制剂
      ≥20.9 mg/mL
      insoluble in H2O
  2. (S)-10-Hydroxycamptothecin
    B4745 (S)-10-Hydroxycamptothecin
    中文名: 羟喜树碱
    Target: Topoisomerases
    Summary: 拓扑异构酶I抑制剂
      ≥23.8 mg/mL
      insoluble in H2O
  3. Ellipticine
    B7382 Ellipticine
    中文名: 玫瑰树碱,椭圆玫瑰树碱
    Target: Topoisomerases
    Summary: DNA拓扑异构酶II抑制剂
      ≥24.6 mg/mL
      insoluble in H2O
  4. Midostaurin (PKC412)
    B3709 Midostaurin (PKC412)
    中文名: 米哚妥林
    Target: PKC|PKA|KDR|Flk1|PPK|c-Syk|CDK1/CyclinB
    Summary: PKC抑制剂
      ≥57.1 mg/mL
      insoluble in H2O
  5. Pirarubicin
    B2295 Pirarubicin
     1 Citation
    中文名: 吡柔比星
    Target: Topoisomerases
    Summary: 拓扑异构酶II抑制剂,蒽环类抗生素
      ≥7.65 mg/mL
      insoluble in H2O
  6. Norfloxacin
    B1801 Norfloxacin
    中文名: 诺氟沙星
    Target: Topoisomerases
    Summary: 拓扑异构酶抑制剂
      insoluble in DMSO
      insoluble in H2O
  7. Irinotecan HCl Trihydrate
    B2293 Irinotecan HCl Trihydrate
    中文名: 盐酸依立替康三水合物
    Target: Topoisomerases
    Summary: 拓扑异构酶I抑制剂
      ≥23.1 mg/mL
      ≥2.5 mg/mL
  8. Beta-Lapachone
    B2290 Beta-Lapachone
    中文名: β-拉帕醌
    Target: Topoisomerases
    Summary: 选择性DNA拓扑异构酶I抑制剂
      ≥10.85 mg/mL
      insoluble in H2O
  9. Clinafloxacin CI96 AM1091
    A8400 Clinafloxacin CI96 AM1091
    中文名: 克林沙星
    Target: Topoisomerases
    Summary: 拓扑异构酶抑制剂
      ≥3.66 mg/mL
      insoluble in H2O
  10. Ofloxacin
    A5511 Ofloxacin
    中文名: 氧氟沙星
    Target: Topoisomerases|DNA gyrase
    Summary: 氟喹诺酮类抗生素
      ≥12.03 mg/mL
      insoluble in H2O

19件产品中的 1-10

页面
每页